期刊文献+

糖皮质激素对过敏性紫癜患儿肾损害预防作用的Meta分析 被引量:29

Meta-analysis on whether early corticosteroid administration reduces the risk of subsequent renal involvement in Henoch-Scholein purpura
下载PDF
导出
摘要 目的评价糖皮质激素对过敏性紫癜患儿肾损害的预防作用。方法检索Cochrane图书馆、MEDLINE、EMBASE、CBM等资料库,收集有关糖皮质激素对过敏性紫癜患儿肾损害预防作用的随机对照研究后进行Meta分析。结果3个随机对照研究符合纳入标准。显示治疗组肾损害的发生率为7.0%(11/158),对照组肾损害的发生率为19.9%(30/151)(RR=0.35,95%CI:0.19-0.65);治疗组未出现明显的不良反应。结论过敏性紫癜患儿早期接受泼尼松治疗可显著减少肾脏损害的发生,且无明显不良反应。但本项分析的试验数较少,且存在研究结果方向的不一致,故仍需要进行大样本、前瞻性、随机对照研究来进一步明确。目前建议糖皮质激素应有选择地早期应用于存在肾脏受累危险因素的高危患儿,以预防肾脏损害。 Objectives Hentich-Schoelein purpura (HSP) is the most common systemic small vessel vasculitis in children. The long-term morbidity and mortality of HSP are predominantly attributable to renal involvement. During the last three decades there were many studies reported the early use of corticosteroids in HSP children without renal involvement; but the question of whether early treatment with corticosteroids reduces the risk of subsequent renal involvement in HSP remains unknown. So it is necessary to use evidence-based medicine to investigate whether early corticosteroid administration could reduce the rate of renal complications in children with HSP. Methods Cochrane library, MEDLINE, EMBASE and CBM were searched and the randomized controlled clinical trials were selected and analyzed with Meta-analysis. Eligible patients were younger than 16 years of age and without renal involvement before the treatment. Results Three randomized controlled clinical trials were selected and the results showed that the incidence of renal involvement in the treatment group and in the controlled group were 7.0 % (11/158) and 19.9 % (30/151) (RR = 0.35, 95 % CI: 0.19 - 0.65) ; respectively. No serious side effects were reported in the treatment group. Conclusions Early corticosteroid administration could reduce the rate of renal complications in children with HSP without obvious serious side effects. But in this analysis the number of studies were not enough to obtain the reliable results. Moreover the results in the selected studies were different. So the prospective randomized controlled clinical trials with large samples are needed. By now it is recommended that corticosteroids Should be used selectively in the patients with high risk factors of renal involvement.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2007年第2期147-150,共4页 Journal of Clinical Pediatrics
关键词 儿童 过敏性紫癜 肾损害 糖皮质激素 children Henoech- Schoelein purpura renal involvement corticosteroid
  • 相关文献

参考文献18

  • 1Calvino MC,Llorca J,Garcia-Porrua C,et al.HenochSchonlein purpura in children from northwestern Spain:a 20-year epidemiologic and clinical study[J].Medicine (Baltimore),2001,80 (5):279-290.
  • 2Huber AM,King J,McLaine P,et al.A randomized,placebo-controlled trial of prednisone in early Hen(o)ch Sch(o)nlein Purpura[J].BMC Med,2004,2:7.
  • 3Buchanec J,Galanda V,Belakova S,et al.Incidence of renal complications in Schonlein-Henoch purpura syndrome in dependence of an early administration of steroids[J].Int Urol Nephrol,1988,20 (4):409-412.
  • 4Saulsbury FT.Corticosteroid therapy does not prevent nepphritis in Henoch-Schonlein purpura[J].Pediatr Nephrol,1993,7 (1):69-71.
  • 5Saulsbury FT.Henoch-Schonlein purpura in children.Report of 100 patients and review of the literature[J].Medicine (Baltimore),1999,78 (6):395-409.
  • 6刘科峰,韩杰,韩冬.过敏性紫癜抗炎疗法的临床研究[J].河南大学学报(医学版),2001,23(4):20-21. 被引量:6
  • 7Trapani S,Micheli A,Grisolia F,et al.Henoch Scholein purpura in childhood:epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature[J].Semin Arthritis Rheum,2005,35 (3):143-153.
  • 8Mollica F,Li Volti S,Garozzo R,et al.Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura[J].Eur J Pediatr,1992,151 (2):140-144.
  • 9Kaku Y,Nohara K,Honda S.Renal involvement in Henoch-Schonlein purpura:a multivariate analysis of prognostic factors[J].Kidney Int,1998,53 (6):1755-1759.
  • 10黄文彦,陈荣华,邬薇,丁桂霞,黄松明.强的松对过敏性紫癜肾损害预防作用的观察[J].南京医科大学学报(自然科学版),2002,22(3):214-216. 被引量:34

二级参考文献35

  • 1衣川直子.血管性紫斑病[J].小儿内科,1992,24:539-539.
  • 2潘健涛,叶家雄.低分子量肝素在血液透析中的应用[J].中华泌尿外科杂志,1997,18(7):430-432. 被引量:26
  • 3[1]Rostoker G.Schonlein Henoch purpura in children and adults: diagnosis, pathophysiology and management[J]. Bio Drugs, 2001, 15(2): 99- 138.
  • 4[2]Saulsbury FT.Henoch Sch nlein purpura in children. Report of 100 patients and review of the literature[J]. Medicine, 1999, 78(6): 395- 409.
  • 5[3]Rai A, Nast C, Adler S.Henoch Sch nlein purpura nephr iis[J].J Am Soc Nephrol, 1999, 10(12): 2637- 2644.
  • 6[4]Davin JC, Weening JJ.Henoch Sch nlein purpura nep hritis: an update[J].Eur J Pediatr, 2001, 160(12): 689- 695.
  • 7[5]Scharer K, Krmar R, Querfeld U, et al.Clinical outcome of Sch nlein Henoch purpura nephritis in children[J]. Pediatr Nephrol, 1999, 13(9): 816- 823.
  • 8[6]Coppo R, Mazzucco G, Cagnoli L, et al.Long term prognosis of Henoch Sch nlein nephritis in adults and children.Italian group of renal immunopathology collaborative study on henoch Sch nlein purpura[J].Nephrol Dial Transplant, 1997, 12(11): 2277- 2283.
  • 9[7]Goldstein AR, White RHR, Akuse R, et al.Long term follow up of childhood Henoch Sch nlein nephritis[J]. Lancet, 1992, 339(5): 280- 282.
  • 10[8]Kaku Y, Nohara K, Honda S.Renal involvement in Henoch Sch nlein purpura: A multivariate analysis of prognostic factors[J].Kidney Int, 1998, 53(6): 1755- 1759.

共引文献56

同被引文献321

引证文献29

二级引证文献574

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部